Johnson and Johnson scraps local trials for its single-shot COVID vaccine in India: Report
New Delhi: Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India and is looking at ways to accelerate its availability in the country, the Economic Times reported on Tuesday, citing a company spokesperson.
J&J said in April it was in talks with India's government to begin a bridging clinical study of its Janssen COVID-19 vaccine candidate in the country.
In late May, India said it would scrap local trials altogether for "well-established" vaccines manufactured in other countries.
The U.S.-based drugmaker is exploring how to accelerate the availability of its vaccine in India, the Economic Times report said.
Over 41 million COVID-19 vaccine doses were administered across India last week, with pandemic-induced restrictions being eased further.
Read also: Industry leaders, top govt officials to participate in India-US Pharma Summit
Experts have said widespread vaccination remains one of the best tools to avoid the kind of devastation India saw during its second wave of the pandemic.
J&J did not immediately respond to a Reuters request for comment.
Read also: COVID-19: Reliance seeks Govt nod to import JnJ vaccine for its workforce in India
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.